March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has notified manufacturers of certain ...

New carbidopa/levodopa labels will state that seizures linked to vitamin B6 deficiency can ...

A drug to treat Parkinson's disease can be made from waste plastic bottles using a pioneering method, a study shows. The approach harnesses the power of bacteria to transform post-consumer plastic ...

Scientists make Parkinson’s drug from used plastic bottles - Researchers said the breakthrough could lead to a ‘bio-upcycling industry’ that uses waste materials to make things like flavourings and ...

Scientists at the University of Edinburgh in Scotland used biologically-engineered E. coli, a bacteria that causes diarrhea, ...

University of Edinburgh researchers have used bacteria to break down plastic waste and turn it into a Parkinson's drug, ...

The approach harnesses the power of bacteria to transform post-consumer plastic into L-DOPA, a frontline medication for the neurological disorder.

Non-invasive treatment at Tuen Mun Hospital offers new option, with 40 patients to be treated within two years Tuen Mun ...

Plus: A biotech turns to wearables and a drug giant beefs up on AI chips.

Scientists engineer E. coli to convert PET plastic bottle waste into L-DOPA, a primary treatment for Parkinson’s disease.

Researchers engineered a two-strain microbial system that converts PET-derived terephthalic acid into levodopa, overcoming key bottlenecks in transport and enzyme inhibition. The proof-of-concept ...